237 related articles for article (PubMed ID: 23136913)
1. Update on rifampin, rifabutin, and rifapentine drug interactions.
Baciewicz AM; Chrisman CR; Finch CK; Self TH
Curr Med Res Opin; 2013 Jan; 29(1):1-12. PubMed ID: 23136913
[TBL] [Abstract][Full Text] [Related]
2. Update on rifampin and rifabutin drug interactions.
Baciewicz AM; Chrisman CR; Finch CK; Self TH
Am J Med Sci; 2008 Feb; 335(2):126-36. PubMed ID: 18277121
[TBL] [Abstract][Full Text] [Related]
3. Rifampin and rifabutin drug interactions: an update.
Finch CK; Chrisman CR; Baciewicz AM; Self TH
Arch Intern Med; 2002 May; 162(9):985-92. PubMed ID: 11996607
[TBL] [Abstract][Full Text] [Related]
4. Update on rifampin drug interactions, III.
Strayhorn VA; Baciewicz AM; Self TH
Arch Intern Med; 1997 Nov; 157(21):2453-8. PubMed ID: 9385296
[TBL] [Abstract][Full Text] [Related]
5. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
Tattevin P; Revest M; Dupont M; Arvieux C; Michelet C
Clin Infect Dis; 2003 Jan; 36(1):127-8. PubMed ID: 12491218
[No Abstract] [Full Text] [Related]
6. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500
[TBL] [Abstract][Full Text] [Related]
7. Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.
Moon SM; Park HY; Jeong BH; Jeon K; Lee SY; Koh WJ
Antimicrob Agents Chemother; 2015 Jan; 59(1):663-5. PubMed ID: 25313207
[TBL] [Abstract][Full Text] [Related]
8. Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
Loeliger A; Suthar AB; Ripin D; Glaziou P; O'Brien M; Renaud-Thery F; Crowley S; Williams B; Ridzon R; Granich R; Gilks C
Int J Tuberc Lung Dis; 2012 Jan; 16(1):6-15. PubMed ID: 21819645
[TBL] [Abstract][Full Text] [Related]
9. Rifapentine: its role in the treatment of tuberculosis.
Temple ME; Nahata MC
Ann Pharmacother; 1999 Nov; 33(11):1203-10. PubMed ID: 10573321
[TBL] [Abstract][Full Text] [Related]
10. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
Hickey MD; Quan DJ; Chin-Hong PV; Roberts JP
Liver Transpl; 2013 Apr; 19(4):457-61. PubMed ID: 23526600
[TBL] [Abstract][Full Text] [Related]
11. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA;
Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
[TBL] [Abstract][Full Text] [Related]
13. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.
Li AP; Reith MK; Rasmussen A; Gorski JC; Hall SD; Xu L; Kaminski DL; Cheng LK
Chem Biol Interact; 1997 Nov; 107(1-2):17-30. PubMed ID: 9402947
[TBL] [Abstract][Full Text] [Related]
14. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
15. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
[TBL] [Abstract][Full Text] [Related]
16. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(42):921-5. PubMed ID: 8927017
[TBL] [Abstract][Full Text] [Related]
17. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
Goldberg SV; Hanson D; Peloquin CA
Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
[No Abstract] [Full Text] [Related]
18. Coadministration of digoxin with itraconazole in renal transplant recipients.
Mathis AS; Friedman GS
Am J Kidney Dis; 2001 Feb; 37(2):E18. PubMed ID: 11157404
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of drug-drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management.
MacDougall C; Canonica T; Keh C; P Phan BA; Louie J
Pharmacotherapy; 2022 Apr; 42(4):343-361. PubMed ID: 35152432
[TBL] [Abstract][Full Text] [Related]
20. Possible clinically significant interaction of itraconazole plus rifampin.
Todd JR; Arigala MR; Penn RL; King JW
AIDS Patient Care STDS; 2001 Oct; 15(10):505-10. PubMed ID: 11689137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
